Oracle Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-70,000
Closed -$8.75M 38
2021
Q3
$8.75M Buy
+70,000
New +$8.32M 1.09% 15

Other funds holding GH

Oracle Investment Management's GH Position: Q4 2021 in Review

Oracle Investment Management sold out of Guardant Health (GH) in Q4 2021, closing a stake of 70,000 shares — an estimated $8.75M sold.

Oracle Investment Management first reported a position in GH in Q3 2021 and held it in 1 quarter. The position peaked at $8.75M in Q3 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Oracle Investment Management reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Oracle Investment Management sold 70,000 Guardant Health shares in Q4 2021, an estimated $8.75M.
  • Oracle Investment Management first reported a position in Guardant Health in Q3 2021 and held it in 1 quarter.
  • Oracle Investment Management's Guardant Health position peaked at $8.75M in Q3 2021.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Oracle Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.